A 30 Day Study to Evaluate Efficacy and Safety of Pre-hospital vs. In-hospital Initiation of Ticagrelor Therapy in STEMI Patients Planned for Percutaneous Coronary Intervention (PCI)

NCT01347580 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

1875

Enrollment

INDUSTRY

Sponsor class

Conditions

Myocardial Infarction
Segment Elevation Myocardial Infarction (STEMI)

Interventions

DRUG: Ticagrelor
DRUG: Placebo

Sponsor

AstraZeneca